Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Genistein
Cat. No.:
0225LY-0511
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Genistein is a soy-derived isoflavone that acts as a multi-target tyrosine kinase inhibitor, providing antioxidant, anthelmintic, and antitumor effects alongside estrogen-like biological activity.
Synonym:
NPI 031L; 446-72-0; Prunetol; 4',5,7-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7,4'-Trihydroxyisoflavone
CAS No.:
446-72-0
Compound CID:
5280961
Formula:
C15H10O5
Formula Weight:
270.24
Specification
Targets&IC50:
EGFR: 0.6 μM (IC50; Cell Assay)
Relative Density:
1.548 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Genistein can be used in endocrine research or serve as a key tool in investigating tyrosine kinase inhibition and estrogenic activity.
Library Information
Target:
EGFR
Receptor:
EGFR
Pathways:
Metabolism; Tyrosine kinase/adaptors; Autophagy; Apoptosis; Angiogenesis; JAK/STAT signaling
Plate Number:
AOCL-7
Plate Location:
f3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
262.5 mg/mL; 971.36 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
2 mg/mL; 7.4 mM
ALogP:
2.14
HBA_Count:
2
HBD_Count:
3
Rotatable Bond:
1
